用药核对:透析患者用药安全的基石
透析患者因多重用药、多种慢性病及肾衰竭导致的药代/药效学改变,药物不良反应风险高。本文通过一例因用药核对不足导致不良结局的病例,综述全球用药差异发生率,阐述有效用药核对及在透析单元的实施考虑,并为透析单元领导提供改进指导。
要点
- 透析患者多重用药及药代/药效学改变,药物不良反应风险高。
- 用药核对是用药安全的基石,尤其在医疗转衔时。
- CMS ESRD质量激励计划新增用药核对要求,需改进实践。
核心结论
- 优先进行用药核对可能改善药物相关问题发生率、用药依从性、医疗费用和生活质量。
研究设计与样本
- 综述性文章,通过一例病例展示用药核对不足的不良结局,并综述全球用药差异发生率的文献。
主要发现
- 透析患者因多重用药、多种慢性病及肾衰竭相关药代/药效学改变而面临较高药物不良反应风险。
- 用药核对不足可在医疗转衔时导致不良结局。
临床怎么用
- 在透析单元实施有效用药核对,并针对CMS ESRD质量激励计划的新要求改进实践。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Medication-related problems are a leading cause of morbidity and mortality. Patients requiring dialysis are at heightened risk for adverse drug reactions because of the prevalence of polypharmacy, multiple chronic conditions, and altered (but not well understood) medication pharmacokinetics and pharmacodynamics inherent to kidney failure. To minimize preventable medication-related problems, health care providers need to prioritize medication safety for this population. The cornerstone of medication safety is medication reconciliation. We present a case highlighting adverse outcomes when medication reconciliation is insufficient at care transitions. We review available literature on the prevalence of medication discrepancies worldwide. We also explain effective medication reconciliation and the practical considerations for implementation of effective medication reconciliation in dialysis units. In light of the addition of medication reconciliation requirements to the Centers for Medicare & Medicaid Services End-Stage Renal Disease Quality Incentive Program, this review also provides guidance to dialysis unit leadership for improving current medication reconciliation practices. Prioritization of medication reconciliation has the potential to positively affect rates of medication-related problems, as well as medication adherence, health care costs, and quality of life.
引用
- Frament J, Hall RK, Manley HJ, et al. Medication Reconciliation: The Foundation of Medication Safety for Patients Requiring Dialysis. Am J Kidney Dis. 2020. PMID: 32920154. doi:10.1053/j.ajkd.2020.07.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。